The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: The Stealth PK Study

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

Jeffrey W. Moses, Martin B. Leon, Jeffrey J. Popma et al. · New England Journal of Medicine · 2003 · 4.2K citations · Full text

Medicine, Cardiology, Surgery +16

A Randomized Comparison of a Sirolimus-Eluting Stent with a Standard Stent for Coronary Revascularization

Marie‐Claude Morice, Patrick W. Serruys, J. Eduardo Sousa et al. · New England Journal of Medicine · 2002 · 4K citations · Full text

Medicine, Cardiology, Pharmacotherapy +11

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

Stephan Windecker, Patrick W. Serruys, Simon Wandel et al. · The Lancet · 2008 · 652 citations

Medicine, Cardiology, Surgery +17

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study

Peter Barlis, E. Regar, Patrick W. Serruys et al. · European Heart Journal · 2009 · 248 citations · Full text

Medicine, Biomedical Engineering, Cardiology +14

Automated, fast and sensitive quantification of drugs in blood by liquid chromatography–mass spectrometry with on-line extraction: immunosuppressants

Uwe Christians, Wolfgang Jacobsen, Natalie J. Serkova et al. · Journal of Chromatography B Biomedical Sciences and Applications · 2000 · 169 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +9